Two years on: Involvement and support

Thank you to everyone who supports our work to drive forward the delivery of the Taskforce’s recommendations.

Our work would not be possible without the involvement and hard work of our Taskforce, Industries Forum and working group members, as well as the invaluable contributions made by people living with lung disease who generously share their personal experiences.

During 2020 we are delighted that the Taskforce membership has grown to 35. We have welcomed:

  • Pulmonary Fibrosis Trust
  • UK Lung Cancer Coalition (UKLCC)

The Industries Forum now has 22 members, with the following members joining in 2020:

  • Merck Sharp & Dohme Limited (MSD)
  • Nowus Healthcare
  • Vitalograph

We are grateful to the sponsors of the Taskforce in 2020. These companies are supporting the work of the Taskforce financially but have no editorial rights:

  • AstraZeneca
  • Chiesi
  • GSK
  • Janssen
  • MSD
  • Novartis
  • Pfizer
  • Sanofi
  • Seqirus
  • Verona Pharma
  • Vitalograph

Further information about the membership and funding of the Taskforce is available here.

In memory of Taskforce supporters

We remember those who have sadly died this year who have contributed their story to help benefit the lives of others with lung disease.

  • Margaret Storey
  • Caroline Dillon